Movano Inc. (NASDAQ:MOVE – Get Free Report) CTO Michael Aaron Leabman sold 6,845 shares of the business’s stock in a transaction on Wednesday, January 14th. The shares were sold at an average price of $6.66, for a total transaction of $45,587.70. Following the completion of the sale, the chief technology officer directly owned 22,639 shares in the company, valued at $150,775.74. This represents a 23.22% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
Michael Aaron Leabman also recently made the following trade(s):
- On Tuesday, January 13th, Michael Aaron Leabman sold 2,076 shares of Movano stock. The stock was sold at an average price of $6.94, for a total value of $14,407.44.
- On Monday, January 12th, Michael Aaron Leabman sold 3,377 shares of Movano stock. The stock was sold at an average price of $7.01, for a total value of $23,672.77.
- On Friday, January 9th, Michael Aaron Leabman sold 783 shares of Movano stock. The shares were sold at an average price of $7.27, for a total transaction of $5,692.41.
- On Thursday, January 8th, Michael Aaron Leabman sold 3,593 shares of Movano stock. The shares were sold at an average price of $7.26, for a total value of $26,085.18.
- On Wednesday, January 7th, Michael Aaron Leabman sold 3,293 shares of Movano stock. The stock was sold at an average price of $7.34, for a total value of $24,170.62.
Movano Price Performance
Shares of MOVE stock opened at $6.92 on Thursday. Movano Inc. has a one year low of $4.67 and a one year high of $58.76. The stock has a market cap of $5.78 million, a P/E ratio of -0.64 and a beta of 0.79. The company has a fifty day moving average price of $8.89 and a two-hundred day moving average price of $7.56.
Movano News Roundup
Here are the key news stories impacting Movano this week:
- Positive Sentiment: Institutional buying: Citadel Advisors added a new stake in Movano in Q3 (49,262 shares), which signals some institutional interest and provides a modest demand anchor for the stock. MarketBeat MOV E profile
- Positive Sentiment: Short interest declined in late December (down ~29% vs. mid‑December), lowering one source of short‑squeeze pressure and marginally reducing downward technical risk. Short interest detail
- Neutral Sentiment: Broader market/geo risk: U.S. stocks were weaker amid rising geopolitical tensions today, which hit small-cap and tech names harder and likely amplified Movano’s downside. RTT News: Market Move
- Negative Sentiment: Significant insider selling — CTO Michael Aaron Leabman sold multiple tranches (e.g., 6,845 shares on Jan. 14 at ~$6.66; earlier sales Jan. 12–13 at ~$7.01–$6.94). Large, clustered insider sales in a low‑float stock can weigh heavily on sentiment and price. SEC filing (Leabman)
- Negative Sentiment: Additional insider selling — CFO Jeremy Cogan disclosed recent sales (8,218 shares on Jan. 6 at ~$7.79 and 1,879 shares on Jan. 5 at ~$8.35), further reducing insider ownership and pressuring sentiment. SEC filing (Cogan)
- Negative Sentiment: Weak fundamentals amplify risk — Movano’s latest quarterly report (Nov. 14) showed a large EPS loss despite beating the consensus loss, with essentially negligible revenue (~$0.08M vs. est. ~$3.9M). For a tiny public company, very low top‑line and deeply negative margins increase execution and dilution risk. Earnings summary
- Negative Sentiment: Structural/analyst backdrop: Movano’s market cap is very small (~$5–6M) with low average volume and an average analyst rating near “Sell” — factors that magnify volatility and make recovery catalysts harder to materialize absent meaningful operational progress. Company profile & ratings
Institutional Trading of Movano
An institutional investor recently bought a new position in Movano stock. Citadel Advisors LLC bought a new position in Movano Inc. (NASDAQ:MOVE – Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 49,262 shares of the technology company’s stock, valued at approximately $28,000. Citadel Advisors LLC owned about 5.94% of Movano at the end of the most recent quarter. Institutional investors own 16.64% of the company’s stock.
Wall Street Analyst Weigh In
Several equities analysts have recently issued reports on the company. Weiss Ratings reiterated a “sell (e+)” rating on shares of Movano in a research note on Wednesday, October 8th. Wall Street Zen raised Movano to a “hold” rating in a report on Saturday, December 20th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock has a consensus rating of “Sell”.
Check Out Our Latest Analysis on MOVE
Movano Company Profile
Movano Health, Inc (NASDAQ: MOVE) is a health technology company focused on developing wearable devices for continuous biometric monitoring. The company’s core mission is to provide accessible, real-time health insights through noninvasive sensors, enabling individuals and care teams to track vital signs and physiological trends outside of traditional clinical settings.
Movano’s flagship product is a biometric monitoring ring designed to measure parameters such as heart rate, blood oxygen saturation, skin temperature, and sleep quality.
Recommended Stories
- Five stocks we like better than Movano
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- Executive Order 14330: Trump’s Biggest Yet
- If You Keep Cash In A U.S. Bank Account… Read This NOW
Receive News & Ratings for Movano Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Movano and related companies with MarketBeat.com's FREE daily email newsletter.
